Quick answer
Tg Therapeutics, Inc. (TGTX) reported revenue of $616.3M and net income of $447.2M for the fiscal year ended 2025-12-31, up 87.3% from $329.0M the year before, per its 10-K filed with the SEC on 2026-02-27. Long-term debt stood at $245.6M.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $616.3M | $447.2M | $245.6M |
| 2024 (FY ending 2024-12-31) | $329.0M | $23.4M | $244.4M |
| 2023 (FY ending 2023-12-31) | $233.7M | $12.7M | $100.4M |
| 2022 (FY ending 2022-12-31) | $2.8M | -$223.8M | $71.1M |
| 2021 (FY ending 2021-12-31) | $6.7M | -$348.1M | $67.8M |
| 2020 (FY ending 2020-12-31) | $0.2M | — | $29.9M |
| 2019 (FY ending 2019-12-31) | $0.2M | — | $29.0M |
| 2018 (FY ending 2018-12-31) | $0.2M | — | $0.0M |
| 2017 (FY ending 2017-12-31) | $0.2M | — | — |
| 2016 (FY ending 2016-12-31) | $0.2M | — | — |
Related
- TER revenue, net income and debt history (Teradyne, Inc.)
- TEVA revenue, net income and debt history (Teva Pharmaceutical Industries Limited)
- TGT revenue, net income and debt history (Target Corporation)
- THG revenue, net income and debt history (Hanover Insurance Group, Inc.)
- TJX revenue, net income and debt history (The TJX Companies, Inc.)
- TKO revenue, net income and debt history (Tko Group Holdings, Inc.)
- TLN revenue, net income and debt history (Talen Energy Corporation)
- TMO revenue, net income and debt history (Thermo Fisher Scientific Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.